🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic malignancy.

“The shining star of our household has dimmed his light for us in this life,” his family stated. “After a lengthy and brave struggle with cancer, we are deeply saddened to announce that Michael D’Angelo Archer, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The record reached the fourth spot on Billboard’s Top R&B Albums chart, went platinum later that year, and received multiple award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his artistic journey into the limelight. The album debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the singer, famously stripped down to his waist, singing straight into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a serious vehicle accident that left him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public outings in the following years.

The musician was scheduled as a headliner for the 2025 music event, but his performance was canceled, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s health in the months leading up to his death, he had apparently been hospitalized for months and in hospice for a fortnight.

D’Angelo’s passing is a clear example of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent types of the illness, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of extraordinarily moving music he leaves behind,” his family said.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a small organ that generates insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the body make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only approximately three percent of malignancy cases each year in the United States, it is responsible for seven percent of cancer deaths.

Almost 70,000 people will be found to have this condition and about 52,000 will die of the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and ineffective therapies, and a smaller window to make a meaningful impact on the well-being of patients,” said a cancer specialist.

Because this disease seldom produces early symptoms, it’s often diagnosed only after the condition is advanced. Although a patient has symptoms they are often vague and may be confused with a number of common illnesses.

“Currently, there is no effective method to detect pancreatic cancer in the early stages, apart from listening to your body and consulting your doctor if there are unfamiliar signs,” said a health expert.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• loss of appetite
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is most common in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become more common in younger adults.

“Pancreatic cancer identified prior to fifty is considered uncommon, yet concerningly, doctors are noticing a growing number of younger individuals suffering from this disease,” said a specialist.

Family History Impacts Cancer Risk

In the absence of reliable screening tools for pancreatic cancer, experts stressed the significance of knowing your family’s cancer history. Certain risk factors, such as tobacco use and obesity also have an influence in the onset of this disease.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be diagnosed with untreatable disease.

“The first step toward lowering one’s risk of this condition is assessing individual susceptibility. People should examine their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may raise their susceptibility,” said a specialist.

Hereditary risk factors are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to consider DNA analysis.

“For people with a family history of pancreatic cancer or those carrying high risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he clarified.

For those looking to reduce their risk, habit adjustments may make a difference. The best step you can take to reduce your susceptibility of this disease is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Excessive alcohol consumption is linked to pancreas inflammation, a risk factor for pancreatic cancer, so limiting or avoiding drinks may help reduce your risk.

Managing your weight or losing weight may also help reduce your risk. Individuals with obesity are 20% more likely to develop pancreatic cancer. This malignancy also occurs more often in people with blood sugar issues, and weight loss can also reduce the risk of type 2 diabetes.

In spite of this disease’s grim outlook, there is reason for optimism.

“We are doing better with treatments and newer mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a specialist.

For many people, however, education about this rare but {dev